Physiologically-based pharmacokinetic (PBPK) models for prediction of saquinavir effect on midazolam pharmacodynamics
Poster Jun 07, 2012
Viera Lukacova, Haiying Zhou, Walter S. Woltosz, Michael B. Bolger
Purpose: To predict the drug-drug interaction effect of saquinavir on midazolam pharmacodynamics (PD).
Methods:The absorption and pharmacokinetics (PK) of midazolam and saquinavir were simulated using a beta version of GastroPlusTM8.0 (Simulations Plus, Inc., Lancaster, CA). Independent saquinavir and midazolam models were previously validated by comparing the simulated plasma concentration-time (Cp-time) profiles with experimental data for intravenous (i.v.) and oral (p.o.) administration for each drug, as well as by comparing the prediction of the observed drug-drug interaction (DDI) of saquinavir on midazolam PK. Models were fitted for several reported PD responses after midazolam administration based on the drug’s unbound Cp-time profiles. The fitted PD models were then used with the earlier prediction of saquinavir’s effect on midazolam PK to estimate the drug-drug interaction effect of saquinavir on midazolam PD.
Results: Baseline PD responses for midazolam (i.e., without saquinavir), such as the digit symbol substitution test (DSST) and the Maddox Wing Test (MWT), were equally well described by several different types of direct or indirect PD models, each resulting in a different prediction of the magnitude of saquinavir’s effect on midazolam PD. Several models predicted the maximum response within 20% of the observed maximum response; however, the prediction error was as high as 40% with other models. In the absence of PD response data for different dose levels of midazolam, there was no obvious most relevant baseline PD model for each response.
Novel lead optimization strategy of BACE I inhibitors for the treatment of Alzheimer’s disease by Quantitative Structure-Activity Relationship (QSAR) and Physiologically-Based Pharmacokinetics (PBPK) modelingPoster
In this study, we introduce an innovative in silico-based high throughput lead optimization strategy with QSAR and PBPK modelings using StarDrop™, ADMET predictor® and GastroPlus®.READ MORE
Platform Agnostic Data Processing Routine for Targeted and Untargeted Metabolite Identification in Drug DiscoveryPoster
A discussion of a new informatics solution that addresses common challenges in metabolite identification and characterization--from LC/MS data processing and metabolites prediction to reporting and databasing of assembled biotransformation knowledge.READ MORE
ROS-Glo™ H2O2 Assay: A Luminescent Assay for Detection of Reactive Oxygen Species PosterPoster
H2O2 is a reactive oxygen species (ROS) that is measured in cells as a marker of oxidative stress. It is also measured as a marker of enzyme activities that either consume or produce H2O2. It is desirable to screen chemical compounds for their capacity to alter H2O2 levels in cultured cells or for their effects on H2O2 levels in enzyme reactions.READ MORE